Arficus with its solution named "MEDHINI"-World's 1st Genomics Large Model(LM's) Generative Artificially Intelligent SAMD(Software as Medical Device) catering pioneering multi-modal solutions with Altruism empowerment towards Rapid-Accurate-Affordable Diagnosis, Anti-microbial resistance-BA/BE-In Silico Virtual Clinical Trials Framework, Climate-Change Impact on Human Health Analysis Framework, Multi-disciplinary Insure-tech Underwriting framework under 5 sectors of Pulmonology,Neurology,Nephrology,Cardiology and Oncology specially focusing on Social Impact Driven Change with a mission of creating "Affordable technology Led Healthcare Accessible for all”

One intelligence platform. Three sovereign capabilities — longevity, pharma sovereignty, biodefense.

Education

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.

Extracted from Arficus Private Limited's own website, fetched Jul 2026. Verification badges reflect format/MX checks, not endorsement.